Walk like a man.

The NHS has announced that new prescriptions of cross-sex hormones for under-18s will be banned following a review that found insufficient evidence supporting their use for treating gender dysphoria in young people. Existing patients may continue treatment. The decision follows recommendations from the review led by Hilary Cass, with a public consultation planned before the policy is finalised.